Key result
Admission biomarkers show no significant link to cardiovascular involvement in pediatric MIS-C.
Why the study?
The association between altered admission biomarkers and cardiovascular involvement in Latin American patients with MIS-C was unclear.
Do admission biomarkers predict cardiovascular involvement in Latin American pediatric patients with MIS-C?
Cohort (n=60)
No
Do admission biomarkers predict cardiovascular involvement in Latin American pediatric patients with MIS-C?
Routine admission biomarkers and male gender do not appear to be significantly associated with cardiovascular involvement in Latin American pediatric patients with MIS-C, though larger studies are needed.
Answers are grounded in this paper and cite their sources.
Admission biomarkers should not guide CV risk assessment in pediatric MIS-C; leaves open need for larger studies to identify predictors.
Objectives The aim of the study is to determine if there is an association between altered biomarkers and cardiovascular involvement in Latin American patients with MIS-C. Design The researchers of this study conducted a retrospective cohort study. Setting Secondary care maternal unit hospital in Monterrey, NL, Mexico. Participants Any register of a Latin-American pediatric patient with MIS-C within the database from March 2019 to February 2022. Primary and secondary outcome measures Cut, mean, odds ratio (OR), relative ratio (RR), 95% confidence interval (CI) and p values of inflammatory markers associated with cardiovascular affection in MIS-C. As a secondary outcome we measure being male as an independent risk factor. Results None of the biomarkers and gender variables taken were significant (Table 1). Conclusions The researchers’ analysis suggests there is no evidence of cause-effect association between admission biomarkers and the presence of cardiovascular affection in MIS-C. Remarkably, neutrophilia and ESR had a high odds ratio and a nearly significant p-value, which makes them ideal for further analysis with a bigger sample. Additionally, gender was included as a risk factor and was analyzed independently, nonetheless, it was not associated with a higher risk of presenting cardiovascular affection. Article summary Strengths and limitations of this study First study measuring the association of a series of available and economical biomarkers with a higher incidence of cardiovascular involvement in MIS-C in a Latin-American population. Set ground for further research regarding the current treatment of MIS-C Sample size non-representative. Since this is an observational study we can’t fully control confounding and bias (e.j. reporting bias)
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2023) conducted a cohort in Multisystem Inflammatory Syndrome in Children (MIS-C) (n=60). Admission biomarkers (e.g., neutrophilia, ESR, CRP) vs. Normal biomarker levels was evaluated on Cardiovascular involvement associated with neutrophilia (OR 2.52, p=0.08). Admission biomarkers were not associated with cardiovascular involvement in Latin American pediatric patients with MIS-C, though neutrophilia and ESR showed a trend toward significance.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: